FDA approves Gilead’s antiviral drug remdesivir to treat COVID-19

Coronavirus

(NEXSTAR) – The U.S. Food and Drug Administration has approved the first drug to treat COVID-19: remdesivir, an antiviral medicine given through an IV for patients needing hospitalization.

The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health.

“The speed and rigor with which we have reached this milestone reflect the shared commitment of Gilead, government agencies and clinical trial investigators to advance new treatment options for patients in the fight against COVID-19,” said Daniel O’Day, chairman and CEO.

It had been authorized for use on an emergency basis since spring, and now has become the first drug to win full U.S. approval for treating COVID-19.

Gilead says Veklury is approved for people at least 12 years old and weighing at least 88 pounds (40 kilograms) who need hospitalization for their coronavirus infection. It works by inhibiting a substance the virus uses to make copies of itself.

The Associated Press contributed to this report.

Latest Stories

Copyright 2021 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Don't Miss

More Don't Miss

Coronavirus News

More Coronavirus

Trending Stories

Don't Miss

Your Local Election HQ

More Election

Local Sports

Appleton North wins first Gold Ball at state soccer

UW-Oshosh claims WIAC softball tourney title, automatic NCAA bid

Marty Paulsen

Appleton North soccer wins first state title

On the Diamond: Ashwaubenon stays unbeaten, Kimberly sweeps baseball and softball

UW-Oshkosh advances to WIAC softball series